HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

3rd Edition of

World Orthopedics Conference

September 15-17, 2025 | London, UK

Ortho 2025

Genetic association between symptoms of mild osteogenesis imperfecta(oi) and Postmenopausal osteoporosis

Speaker at World Orthopedics Conference 2025 - Eiman Shahrour
Tishreen University, Syrian Arab Republic
Title : Genetic association between symptoms of mild osteogenesis imperfecta(oi) and Postmenopausal osteoporosis

Abstract:

Background-Aim: Mild osteogenesis imperfecta OI and postmenopausal osteoporosis are both bone disorders. Mild OI may be associated with postmenopausal osteoporosis. According to NCBI, COL1A2rs72658152 (COL1A2G661S) is a pathogenic proven cause of the association between mild OI and postmenopausal osteoporosis. The challenges facing DEXA and the treatment plans of the World Health Organization WHO for osteoporosis require a search for new diagnostic solutions such as genetic methods.

Methods: COL1A2rs72658152 was detected by Restriction Fragment Length Polymorphism RFLP and DNA sequencing on 150 EDTA blood samples from pre and post menopause women in Tishreen University Hospital. BMD was measured using DEXA. A clinical examination was conducted for the participants. A questionnaire was filled out with information related to the study. Related-Samples McNemar Change Test, Chi-Square Test, and binary logistic regression was used as a statistical method to estimate the correlation between mild OI and postmenopausal (osteopenia or osteoporosis) under 95% confidence level (α ≤ .050) as well as the correlation between (mild OI, postmenopausal osteoporosis or osteopenia) and some morphological characteristics under 95% confidence (α≤ .050).

Results: The significant chance to the occurrence of mild OI with postmenopausal osteopenia or osteoporosis is 10.8% with confidence level of 95% or more (p ≤.05). Strong asymptotic significance of (2-sided) correlation is found between mild OI, on one hand, and postmenopausal osteopenia or osteoporosis on the other (Chi-Square = 29.066, p=.000< .05(. Mild OI has a significant impact on postmenopausal osteoporosis or osteopenia (p= .000<.05). They are in positive correlation relationship according to the nature of tendency slop (B=1.758).

Conclusions: Mild OI is associated with postmenopausal osteopenia and osteoporosis with statistical significance with reasons other than COL1A2G661S, and no specific morphological characteristics are found. Postmenopausal osteoporosis is not a primary osteoporosis because there are causes for it to occur. This is contrary to WHO classification.

Biography:

Dr.Eiman Shahrour is a Syrian researcher who holds a Bachelor's degree in Pharmacy 2013, a Master's degree in Laboratory Diagnosis 2017, and a PhD in Clinical Biochemistry, currently underway, from Lattakia University (formerly Tishreen University). She has published many articles on the genetics of osteoporosis and has won international awards on the same topic, as well as invitations to dozens of international conferences related to the same topic. She is also the founder of the promising EMS strategy to solve the challenges facing the diagnosis and treatment of osteoporosis.

Watsapp